Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence

Melanoma

The main purpose of this study is to compare the efficacy of bempegaldesleukin plus nivolumab versus nivolumab in patients with completely resected Stage IIIA / B / C / D, or Stage IV cutaneous melanoma who are at high risk for recurrence.
Melanoma
III
Johnson, Douglas
NCT04410445
VICCMEL2066

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: